Daewoong Pharmaceutical Co., Ltd (KRX: 069620)
South Korea flag South Korea · Delayed Price · Currency is KRW
125,500
-3,400 (-2.64%)
Dec 19, 2024, 3:30 PM KST

Daewoong Pharmaceutical Company Description

Daewoong Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally.

It offers products in therapeutic areas, such as central nervous system, endocrinology, musculoskeletal, nephrology, antineoplastic, cardiovascular, gastrointestinal, metabolic, antiviral, analgesic, antacid, and digestive diseases, as well as wound, iron supplements, and muti-vitamins.

The company also provides COVID-19 PCR kit, COVID-19 IgG/IgM RDT, and viral transport medium medical devices.

The company was founded in 1945 and is headquartered in Seoul, South Korea.

Daewoong Pharmaceutical Co., Ltd
Daewoong Pharmaceutical logo
Country South Korea
Founded 1945
Industry Drug Manufacturers - Specialty & Generic
Sector Healthcare
Employees 1,727

Contact Details

Address:
12, Bongeunsa-ro 114-gil
Seoul, 135-715
South Korea
Phone 82 2 550 8209
Website daewoong.com

Stock Details

Ticker Symbol 069620
Exchange Korea Stock Exchange
Fiscal Year January - December
Reporting Currency KRW
ISIN Number KR7069620003
SIC Code 2834

Key Executives

Name Position
Seongsoo Park Chief Executive Officer and Executive Director
Chang-Jae Lee Chief Executive Officer and Executive Director
Eunkyeong Park Executive Director